NCT05433987 Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy Status COMPLETED Phase N/A
NCT05421286 The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05418790 A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy Status UNKNOWN Phase NA
NCT05414786 A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) Status UNKNOWN Phase PHASE1
NCT05411237 Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma Status NOT_YET_RECRUITING Phase PHASE3
NCT05405582 Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa Status RECRUITING Phase NA
NCT05374109 SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth Status ACTIVE_NOT_RECRUITING Phase NA
NCT05349838 Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N Status COMPLETED Phase PHASE3
NCT05332470 A Real-world Study of Lamivudine and Dotiravir Sodium Tablets in the Treatment-naïve HIV-1 Infected Patients Status UNKNOWN Phase N/A
NCT05330143 Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV Status COMPLETED Phase PHASE2
NCT05314088 Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV Status COMPLETED Phase NA
NCT05306704 High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial Status COMPLETED Phase PHASE3
NCT05281510 Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women Status COMPLETED Phase PHASE2
NCT05275998 TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals Status COMPLETED Phase PHASE1/PHASE2
NCT05271370 An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study Status TERMINATED Phase PHASE2/PHASE3
NCT05222945 A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide Status NOT_YET_RECRUITING Phase NA